Proceedings of the 6th Meeting of the EBMT Paediatric Diseases Working Party and 1st Meeting of the EBMT Paediatric Nurses

Introduction

• G Dini
• F Locatelli
• on behalf of the EBMT Paediatric Diseases Working Party

Metachromatic leukodystrophy: an overview of current and prospective treatments

• A Biffi
• G Lucchini
• M Sessa

Place of HSCT in treatment of childhood AML

• T Klingebiel
• D Reinhardt
• on behalf of the EBMT Paediatric Diseases Working Party

Allo-SCT in children with high-risk leukemia using unmanipulated grafts from alternative donors

• P Sedlacek
• E Mejstrikova
• J Stary

Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma

• A Claviez
• A Sureda
• N Schmitz

Allogeneic or haploidentical HSCT for refractory or relapsed solid tumors in children: toward a neuroblastoma model

• J Kanold
• C Paillard
• F Deméocq

Monitoring of post-transplant remission of childhood malignancies: is there a standard?

• P Bader
• A Willasch
• T Klingebiel

Where should adolescents with ALL be treated?

• G Dini
• L Banov
• on behalf of the EBMT Paediatric Diseases Working Party

Innovative approaches of targeted therapy for CML of childhood in combination with paediatric haematopoietic SCT

• M Suttorp

The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis

• N Cooper
• K Rao
• P Veys

HSCT for Fanconi anemia in children: factors that influence early and late results

• J-H Dalle

Haploidentical SCT in children: an update and future perspectives

• P Lang
• R Handgretinger

Potential role of mesenchymal stromal cells in pediatric hematopoietic SCT

• L M Ball
• M E Bernardo
• R M Egeler

Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT

• F K Główka
• M Karaźniewicz-łada
• J Wachowiak

Role of HLA in hematopoietic SCT

• J Nowak

Prevention of infectious complications in pediatric HSCT

• J Styczynski
• L Gil
• on behalf of the EBMT Paediatric Diseases Working Party

JACIE accreditation in paediatric haemopoietic SCT

• J M Cornish

Quality of life and ethical and legal dilemmas in children during and after hematopoietic SCT procedure

• A Chybicka

Assessing the risk of transplant-related complications and individually tailoring the HSCT procedure in children and adolescents—is it possible?

• M Faraci
• G Dini
• on behalf of the Paediatric Diseases Working Party

Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia

• M Führer

Innovative approaches to treat steroid-resistant or steroid refractory GVHD

• M Berger
• E Biasin
• F Fagioli

Oral and Poster presentations